Breast Biopsy Devices Market is projected to grow to around US$ 3.77 billion by 2033 | Argon Medical Devices, Danaher Corporation, Cigna, Siemens Healthcare, Hologic Inc, Devicor Medical Products

The Breast Biopsy Devices Market was valued at approximately US$ 2.25 billion in 2024 and is projected to grow to around US$ 3.77 billion by 2033, registering a compound annual growth rate (CAGR) of 6.1% from 2025 to 2033.

The Breast Biopsy Devices Market report by DataM Intelligence provides comprehensive insights and analysis on key market trends, growth opportunities, and emerging challenges. With a commitment to delivering actionable intelligence, DataM Intelligence empowers businesses to make informed decisions and stay ahead of the competition. By combining qualitative and quantitative research methodologies, the firm delivers in-depth reports that help clients navigate complex market dynamics, drive strategic growth, and seize new opportunities in an ever-evolving global landscape.

Download your exclusive sample report today: (corporate email gets priority access): https://datamintelligence.com/download-sample/breast-biopsy-devices-market?sg

Breast Biopsy Devices Market Overview:

A breast biopsy is a diagnostic procedure that involves extracting a small sample of breast tissue to determine the nature of an abnormality. It is performed to assess whether a suspicious area in the breast is cancerous or non-cancerous. The collected tissue is examined by pathologists-medical specialists who diagnose diseases through laboratory analysis. Among the available diagnostic methods for breast cancer, biopsy remains the most reliable, as it provides clear confirmation of the presence or absence of malignant cells.

There are several types of breast biopsy techniques, each employing specific imaging methods for guidance. Two commonly used minimally invasive approaches are core needle biopsy (CNB) and vacuum-assisted biopsy (VAB). In CNB, a hollow needle extracts small cylindrical samples of tissue, while VAB uses suction to collect multiple samples through a single insertion point. Other options include fine needle aspiration (FNA), which uses a thin needle to withdraw fluid or cells, and surgical biopsies that involve making an incision to remove larger tissue sections. The choice of biopsy technique is typically based on the nature and location of the abnormality identified during imaging tests like mammography, ultrasound, or MRI.

Breast Biopsy Devices Industry Trends:

Rising Demand for Breast Biopsy Devices
The global breast biopsy market is witnessing steady growth, largely fueled by the growing demand for biopsy procedures. This demand is being driven by several key factors, including the increasing incidence of breast cancer, advancements in diagnostic technologies, greater public awareness, and the introduction of new products and regulatory approvals.

As breast cancer remains one of the most commonly diagnosed cancers globally, the need for early and precise diagnostic methods is becoming increasingly vital. According to the Union for International Cancer Control (UICC), breast cancer is the most frequently diagnosed cancer among women in 157 countries, accounting for approximately one in four cancer cases. It is also the second most prevalent cancer across both genders and a leading cause of cancer-related deaths among women. In 2022 alone, an estimated 2.3 million new breast cancer cases were expected, making up about one in every nine cancers diagnosed globally across sexes. Furthermore, the disease was projected to cause over 669,000 deaths in 2022, with a significant proportion occurring in low-income regions.

This growing burden of breast cancer is prompting healthcare providers to emphasize early detection, where biopsy procedures play a crucial role. By enabling accurate diagnosis, breast biopsies help guide appropriate treatment plans and improve patient outcomes, thereby boosting the demand for biopsy devices worldwide.

Make an Enquiry for purchasing this Report @ https://www.datamintelligence.com/enquiry/breast-biopsy-devices-market?sg

Strategic Players Driving the Breast Biopsy Devices Market: STERYLAB S.r.l., Argon Medical Devices, Danaher Corporation, Cigna, Siemens Healthcare Private Limited, BD, Hologic, Inc., Devicor Medical Products, Inc., F. Hoffmann-La Roche Ltd, Cook.

Research Methodology:

The global Breast Biopsy Devices Market research report employs a comprehensive dual-source approach, integrating both primary and secondary data collection methods to ensure robust market analysis. Our research framework systematically evaluates multiple industry-influencing variables, including regulatory frameworks and government policies, prevailing market conditions, competitive intensity levels, historical performance data, current market positioning, technological innovations and disruptions, emerging industry developments, cross-sector business impacts, market volatility patterns, growth prospects, potential market barriers, and strategic challenges facing industry participants.

Segment Covered in the Breast Biopsy Devices Market:

By Product (Biopsy Needles, Biopsy Tables, Biopsy Wires, Guidance Systems, Others)

By Technique Type (Fine Needle Aspiration Biopsy, Core Needle Biopsy, Biopsy Markers, MRI-Guided Core Needle Biopsy, Surgical Biopsy, Wire Localization, Sentinel Node Biopsy)

By Guidance Technology (Fine Ultrasound-Guided, Mammography-Guided Magnetic Resonance, CT-Guided Biopsy, Others)

By End-User (Hospitals, Diagnostic Centers, Other)

Stay informed with the latest industry insights-start your subscription now: https://www.datamintelligence.com/reports-subscription?sg

Latest Developments:

✅ RadNet completes acquisition of iCAD for $103 million

RadNet finalized its acquisition of artificial intelligence breast‐cancer vendor iCAD at $3.61/share (~$103 M) on July 17, 2025.

✅ In November 2024, Mammotome introduced the Mammotome AutoCore, a groundbreaking core biopsy system featuring spring-loaded, single-insertion technology. This innovation is designed to enhance the efficiency of ultrasound-guided breast biopsy procedures while also improving patient comfort. By allowing clinicians to obtain tissue samples through just one insertion, the AutoCore simplifies the procedure and reduces overall complexity, marking a significant advancement in breast biopsy technology.

Regional Analysis for Breast Biopsy Devices Market:

⇥ North America (U.S., Canada, Mexico)

⇥ Europe (U.K., Italy, Germany, Russia, France, Spain, The Netherlands and Rest of Europe)

⇥ Asia-Pacific (India, Japan, China, South Korea, Australia, Indonesia Rest of Asia Pacific)

⇥ South America (Colombia, Brazil, Argentina, Rest of South America)

⇥ Middle East & Africa (Saudi Arabia, U.A.E., South Africa, Rest of Middle East & Africa)

Most Frequently Asked Questions in the Breast Biopsy Devices Market Research Industry:

➠ Who leads the Breast Biopsy Devices industry and what's their competitive positioning regarding capacity, performance, and profitability?

➠ What growth opportunities and market challenges do Breast Biopsy Devices market vendors face?

➠ Which segments show the highest growth potential and market share distribution?

➠ What factors are driving or limiting Breast Biopsy Devices market growth?

➠ What are the dominant sales and distribution strategies in the Breast Biopsy Devices industry?

Contact Us -
Company Name: DataM Intelligence
Contact Person: Sai Kiran
Email: Sai.k@datamintelligence.com
Phone: +1 877 441 4866
Website: https://www.datamintelligence.com

About Us -
DataM Intelligence is a Market Research and Consulting firm that provides end-to-end business solutions to organizations from Research to Consulting. We, at DataM Intelligence, leverage our top trademark trends, insights and developments to emancipate swift and astute solutions to clients like you. We encompass a multitude of syndicate reports and customized reports with a robust methodology.

Our research database features countless statistics and in-depth analyses across a wide range of 6300+ reports in 40+ domains creating business solutions for more than 200+ companies across 50+ countries; catering to the key business research needs that influence the growth trajectory of our vast clientele.

This release was published on openPR.